Phibro Animal Health (PAHC) Gains from Investment Securities (2013 - 2026)

Phibro Animal Health's Gains from Investment Securities history runs 14 years deep, the most recent figure standing at -$1.9 million for Q1 2026.

• In Q1 2026, Gains from Investment Securities fell 164.77% year-over-year to -$1.9 million; the TTM figure through Mar 2026 stood at $16.1 million (up 465.93% YoY), while the FY2025 annual figure was $4.5 million, up 646.94% from the prior year.
• Gains from Investment Securities was -$1.9 million for Q1 2026 at Phibro Animal Health, down from $3.2 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $14.8 million in Q2 2025 to a low of -$3.2 million in Q4 2024.
• Historically, Gains from Investment Securities has averaged $709823.5 across 5 years, with a median of -$57000.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities sank 5543.86% in 2024, then soared 586.98% in 2025.
• A 5-year view of Gains from Investment Securities shows it stood at -$345000.0 in 2022, then jumped by 83.48% to -$57000.0 in 2023, then tumbled by 5543.86% to -$3.2 million in 2024, then surged by 198.48% to $3.2 million in 2025, then slumped by 160.42% to -$1.9 million in 2026.
• The last three Gains from Investment Securities figures came in at -$1.9 million (Q1 2026), $3.2 million (Q4 2025), and $105000.0 (Q3 2025), per Business Quant data.